Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06094192 · ClinicalTrials.gov registry record · NA
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
A NA study of Alzheimer Disease, sponsored by Boston University Charles River Campus.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 1
- Study location
NCT06094192: Recruiting NA study of Alzheimer Disease, sponsored by Boston University Charles River Campus.
NCT06094192 is a NA study of Alzheimer Disease that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 204 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06094192, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by Boston University Charles River Campus.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will evaluate the theory that Alzheimer's disease-related memory impairment derives from the inefficient orchestration of rhythmic activity at the level of large-scale cortical networks. The results as expected to elucidate AD-related pathophysiology and set groundwork for the development of drug-free interventions for improving memory in AD and related dementias.
Primary Outcome
The accuracy of task performance on memory test
Conditions Studied
Interventions
- DEVICE High definition transcranial electrical current stimulation
Study Locations (1)
Massachusetts
- 677 Beacon St. Room 308 - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT06094192 shows while recruiting
NCT06094192 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which High definition transcranial electrical current stimulation is the first listed.
NCT06094192 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06094192 about?
NCT06094192 is a clinical study titled "Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation". The investigators will evaluate the theory that Alzheimer's disease-related memory impairment derives from the inefficient orchestration of rhythmic activity at the level of large-scale cortical networks. The results as expected to elucidate AD-related pathophysiology and set groundwork for the deve...
What is the current status of trial NCT06094192?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2023-12-20. Estimated completion is 2028-05-31.
What conditions does trial NCT06094192 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT06094192?
The interventions under investigation include: High definition transcranial electrical current stimulation (DEVICE).
Who is sponsoring clinical trial NCT06094192?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06094192 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06094192's enrollment target sits among peer trials
204 103rd of 306 higher than 204 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI